BackFonar Overview

Fonar EBIT

Fonar's EBIT is $10M, below the Healthcare sector average of $23B.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$2.44M
33.26% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

$10.02M
20.51% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Fonar (FONR) FAQ

Fonar (FONR) currently reports a EBIT of $10M as of March 2026. That compares with $13M in the prior-year period — down 20.5% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Fonar's EBIT history and peer comparisons.

Fonar's EBIT decreased from $13M to $10M — a 20.5% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Fonar's EBIT of $10M is lower than the Healthcare sector average of $23B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Fonar reported $10M in EBIT as of March 2026. That compares with $13M in the prior-year period — down 20.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $10M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Fonar, and consider following FONR for alerts when major investors trade the stock.